Goldman Sachs expects Nvidia ’beat and raise,’ lifts price target to $240
Prenetics Global Limited (PRE) completed a public offering of 2,722,642 Class A ordinary shares and associated warrants, raising approximately $44 million in gross proceeds. The health sciences company sold shares at $16.08 each, along with two series of warrants to purchase additional shares.
The Class A warrants carry an exercise price of $24.12 per share, while Class B warrants are priced at $32.16 per share. Both warrant series are immediately exercisable and remain valid for five years from issuance.
The company stated it will use the proceeds to fund global expansion of its IM8 consumer brand and to accumulate Bitcoin as part of what it describes as a dual health and wealth strategy. According to the press release, Prenetics has been purchasing one Bitcoin daily and held 275 Bitcoin as of October 27, 2025.
Dominari Securities LLC served as the sole placement agent for the offering. The securities were offered under a shelf registration statement declared effective by the Securities and Exchange Commission on September 11, 2025.
The final proceeds of $44 million were lower than the approximately $48 million initially announced, reflecting deductions for placement agent fees and offering expenses.
Prenetics describes itself as a health sciences company and states that IM8, co-founded with David Beckham, reached $100 million in annual recurring revenue within 11 months of launch. The company characterizes itself as the first consumer health company to establish a Bitcoin treasury strategy.